NEW YORK, June 9 (GenomeWeb News) - Invitrogen's shares were up 3.6 percent, or $2.29, at $65.37 in mid-afternoon trading after Bears Sterns upgraded the company's stock to "Outperform" from "Peer Perform" today.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.